The vector of anti-telomerase catalytic subunit protein T cell receptor (TCR) is constructed for the engineering of T cell to target Human telomerase catalytic subunit protein. The T cells are genetically modified through transduction with a retroviral vector expressing telomerase catalytic subunit protein-specific T cell receptor. And the vector product was designed for the treatment of cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C522||Lenti-telomerase catalytic subunit protein T cell receptor (Cysteine-modiﬁed) Viral Particle|
|TCR-L112||Human anti-TERT (VYGFVRACL) T Cell Receptor, pGMT7|
|VP-TCR-C521||Lenti-telomerase catalytic subunit protein T cell receptor Viral Particle|
|TCR-L113||Human anti-TERT (VYGFVRACL) T Cell Receptor[Cysteine-modiﬁed], pGMT7|
|VP-TCR-C519||Lenti-TERT T cell receptor (ILA1β2) Viral Particle|
|VP-TCR-C520||Lenti-TERT T cell receptor Viral Particle|
|TCR-L112Z||Human anti-telomerase catalytic subunit protein (aa461-469) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|TCR-L232||Mouse anti-TERT T cell receptor, pCDTCR1|
|TCR-C246Z||Human anti-TERT T cell receptor (ILA1β2), pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved